Advertise
NEWSLETTER
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
AI & Longevity
Margaretta Colangelo

Interview with Margaretta Colangelo

Alex Zhavoronkov is pushing for us to examine how and when to classifying aging and how it should be implemented to overcome "inherent challenges"

Applying AI approaches to diverse aging-related problems

Extending healthspan with NaNot nano-extractors

Lou Hawthorne, CEO, NaNotics
Margaretta Colangelo

Margaretta Colangelo in conversation with Richard Siow, John Shepherd, and Alexander Zhavoronkov

NetraMark CEO

Uncovering the heterogeneity & etiology of aging

Tina Woods

From cells to cities

AI enables a holistic approach to Superlongevity

Using AI to decode and encode the signals from the brain to the body

Leveraging AI, genomics, and biobanks to identify and target the molecular drivers of aging

‘AI & Longevity’ Ask Me Anything

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE

  • $617BN - Annual global revenue by 2045
  • $30BN+ - Invested in under 2 years
  • 3,036 - Therapeutics individually assessed